Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency

Paul Bastard, Jeremy Manry, Jie Chen, Jérémie Rosain, Yoann Seeleuthner, Omar AbuZaitun, Lazaro Lorenzo, Taushif Khan, Mary Hasek, Nicholas Hernandez, Benedetta Bigio, Peng Zhang, Romain Lévy, Shai Shrot, Eduardo J.Garcia Reino, Yoon Seung Lee, Soraya Boucherit, Mélodie Aubart, Rik Gijsbers, Vivien BéziatZhi Li, Sandra Pellegrini, Flore Rozenberg, Nico Marr, Isabelle Meyts, Bertrand Boisson, Aurélie Cobat, Jacinta Bustamante, Qian Zhang, Emmanuelle Jouangy, Laurent Abel, Raz Somech, Jean Laurent Casanova, Shen Ying Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Abstract

Inborn errors of TLR3-dependent IFN-α/β- and IFN-λ-mediated immunity in the CNS can underlie herpes simplex virus 1 (HSV-1) encephalitis (HSE). The respective contributions of IFN-α/β and IFN-λ are unknown. We report a child homozygous for a genomic deletion of the entire coding sequence and part of the 3'-UTR of the last exon of IFNAR1, who died of HSE at the age of 2 years. An older cousin died following vaccination against measles, mumps, and rubella at 12 months of age, and another 17-year-old cousin homozygous for the same variant has had other, less severe, viral illnesses. The encoded IFNAR1 protein is expressed on the cell surface but is truncated and cannot interact with the tyrosine kinase TYK2. The patient's fibroblasts and EBV-B cells did not respond to IFN-α2b or IFN-β, in terms of STAT1, STAT2, and STAT3 phosphorylation or the genome-wide induction of IFN-stimulated genes. The patient's fibroblasts were susceptible to viruses, including HSV-1, even in the presence of exogenous IFN-α2b or IFN-β. HSE is therefore a consequence of inherited complete IFNAR1 deficiency. This viral disease occurred in natural conditions, unlike those previously reported in other patients with IFNAR1 or IFNAR2 deficiency. This experiment of nature indicates that IFN-α/β are essential for anti-HSV-1 immunity in the CNS.

Original languageEnglish
Article numbere139980
JournalJournal of Clinical Investigation
Volume131
Issue number1
DOIs
StatePublished - 4 Jan 2021

Funding

FundersFunder number
ANR-12-BSV3-0013-01
ANR-14-CE14-0008-01ANR-18-CE15-0020-02
CNSVIRGENANR-19-CE15-0009-01
Fonda-tion Bettencourt-Schueller
French Foundation for Medical Research
Integrative Biology of Emerging Infectious Diseases Laboratory of ExcellenceANR-10-LABX-62-IBEID
MYCOPARA-DOXANR-16-CE12-0023
US Department of Health and Human ServicesVSRNV000006
University of Paris
National Institutes of HealthR01AI088364, R01NS072381
National Institute of Allergy and Infectious DiseasesR21AI151663
St. Giles FoundationEA20170638020
National Center for Advancing Translational SciencesUL1TR001866
Qatar National Research FundNPRP9-251-3-045
Rockefeller University
Agence Nationale de la RechercheANR-10-IAHU-01
Institut national de la santé et de la recherche médicale
Fondation pour la Recherche MédicaleEQU201903007798
Fonds Wetenschappelijk OnderzoekG0C8517N

    Fingerprint

    Dive into the research topics of 'Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency'. Together they form a unique fingerprint.

    Cite this